Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-25-001831
Filing Date
2025-01-24
Accepted
2025-01-24 16:52:45
Documents
6
Effectiveness Date
2025-01-24

Document Format Files

Seq Description Document Type Size
1 FORM S-8 gnpx20241205_s8.htm S-8 55897
2 EXHIBIT 5.1 ex_754535.htm EX-5.1 8792
3 EXHIBIT 23.1 ex_754536.htm EX-23.1 3060
4 EXHIBIT 23.2 ex_767989.htm EX-23.2 2556
5 EXHIBIT FILING FEES ex_754538.htm EX-FILING FEES 16551
6 lslogo.jpg GRAPHIC 6127
  Complete submission text file 0001437749-25-001831.txt   96476
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-284492 | Film No.: 25554791
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)